BioSpace News Archive

City of Hope, a world-renowned independent cancer research and treatment center, and its affiliate, Translational Genomics Research Institute (TGen), have announced a letter of intent to develop a state-of-the-art cell therapy manufacturing facility in the Phoenix Metropolitan Area, a move that would improve the speed at which stem cell research and cancer treatment is delivered.

$3M initial commitment from Alana Foundation, H. Lundbeck A/S and AC Immune SA

Safe Rx today announced a special promotion in support of new California regulations that require chain pharmacies to carry safe storage devices near the pharmacy counter as a response to the national opioid epidemic.

A California Court of Appeal has affirmed the trial court’s ruling in favor of Aya Healthcare (“Aya”) in a lawsuit brought by its competitor AMN Healthcare, Inc. (“AMN”).

Personalised polytherapeutic healthcare is the future. Leading this future is Hevilo Life Sciences with the introduction of Bespoke Personalised Healthcare (BPH) – an exclusive concierge service for individuals with the resources to facilitate greater control over their healthcare decisions.

With Canada once again debating public drug coverage, a new Conference Board of Canada report assesses different options for national pharmacare against key objectives identified earlier this year by senior health leaders.

Joule, a Canadian Medical Association (CMA) subsidiary, today announced the recipients for its annual Innovation grants.

Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, today announced their CEO, Eyal Barad, will speak on a panel at the Marijuana Business Conference

According to data compiled by Verified Market Intelligence, the global marijuana market was valued at USD 42.2 Billion in 2017 and is projected to reach USD 466.81 Billion

Medela’s negative pressure wound therapy (NPWT) product line on a national basis.